MDT Deal Part Doh!,
To the group - I am very skeptical of anyone who would present their opinions, of any prior company (TMDI) events as speculation that any positive future events for TMDI, or an increase in share price are not distinct possibilities. Much of the information below including dates and events are found on the company website.
My messages are for informational purposes only, and not for any particular outcome. Any conclusions are my own. Please come to your own conclusions without consideration of what I write.
1) Who would negotiate a settlement of a purported $5M consulting lawsuit (public announcement 06.09.20 settlement of $1.050M), while at the same time announcing publicly that they entered into an agreement with MDT for $10M license for IP, and $18M public offering disclosed 06.04.20?
Check those dates. TMDI gets $1.5M 04.29.20, and settles the lawsuit for $1.050 prior to 06.09.20. Why get a loan from MDT for $1.5M AT ALL? They just announced an $10M IP deal AND an $18M offering - which closed in 2 days?????? How convenient, and quite the coincidence. Answer: I wouldn't. Negotiating the settlement while announcing the IP and dev agreements is not a prudent strategy to settle for a lower amount. The time difference between the settlement and loan amount (by 30 days) is inconsequential. If you're familiar with negotiating anything.
2) Pure speculation "MDT could have offered the BOD $2/share?" - Why would TMDI consider selling for $2/share? Less than $300M? ENOS is in the final stages of being finished with the potential (IMO) to generate approximately $22B during the course of the next 25 years. No one knows if there was any conversation regarding an offer, or for any amount. Clearly there's a risk to keep the company - while it will take more time and funding to get to CE/FDA approval - may be worth it. That's for the audience to draw their own conclusions. The question is why did 2 members of the Board leave? IDK. Leaving may be viewed as a form of protest, but doesn't make sense b/c ENOS is in its final stages of completion. It's a mystery to me.
3) Unless someone can remove the agreement redactions, the instruments and camera are only referenced in the IP licenses, that which I'm aware. Please feel free to inform me if otherwise. No one knows if they are being applied to anything in the development agreement.
Further, sight is the most important of the 5 senses. ENOS lights and cameras should be a critical feature, which they are. Regardless of any insinuations to the contrary regarding Dr. Estapes pronouncements as to the effectiveness of both.
If anyone reading this message has direct experience using ENOS, please let us know. Should anyone believe anything presented in direct opposition with an RAS KOL, without having direct knowledge or experience with ENOS? I don't, and I'm not asking anyone to believe me either.
4) Pure conjecture.
5) While presentation style leaves me wanting, the lack of any comments regarding the partnership after milestone 4 is not surprising at all. If they are discussing extending the relationship, it's possible that the subject can't be broached.
6) Differentiation is arbitrary. The surgeon workstation is specifically designed to extend the professional life of a surgeon, as to how they may be able to perform surgery. Instead of standing over a patient, and manually manipulating instruments.
ENOS appears to be more comfortable than placing your face between the cheeks of an elephant. IMO. Smile. If anyone has seen another RAS device use a similar configuration please let us know. Otherwise it would appear to be a less desirable design from which to place a surgeons head. Further to the point of differentiation, John Deere, Ford and Chevy didn't do much product differentiation until much later than their initial products. I'd conclude if it does what it's supposed to do, with as much surgeon input pre prototype, then it will work. If it didn't - then I don't think we would have seen the most recent video from Dr. Estape. The RAS daVinci surgeon with more than +7000 procedures.
I'm ok with "please buy me." But only for a good price as compared to many references in the current company presentation. I conclude we're worth more than those references. JMO.
If anyone else has corporate/medical/anything other than mortgage or vehicle lease negotiation experience - let's hear your opinion(s) as to how you would do this.
Good luck to all. Regards,BK.
AI
